Reasons to Add Cardinal Health (CAH) to Your Portfolio Now

Cardinal Health Inc. (CAH) is well-poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment. However, inflationary pressure remains a concern.Shares of this Zacks Rank #2 (Buy) company have rallied 39.7% compared with the industry's growth of 9.5%. The S&P 500 Index has increased 25.4% in the same time frame.CAH, with a market capitalization of $27.1 billion, is a nationwide drug distributor and service provider to pharmacies, healthcare p ...